Matches in SemOpenAlex for { <https://semopenalex.org/work/W3139794340> ?p ?o ?g. }
- W3139794340 endingPage "1693" @default.
- W3139794340 startingPage "1693" @default.
- W3139794340 abstract "Numerous combinations of signaling pathway blockades in association with tyrosine kinase inhibitor (TKI) treatment have been proposed for eradicating leukemic stem cells (LSCs) in chronic myeloid leukemia (CML), but none are currently clinically available. Because targeting protein kinase Cδ (PKCδ) was demonstrated to eliminate cancer stem cells (CSCs) in solid tumors, we evaluated the efficacy of PKCδ inhibition in combination with TKIs for CML cells. We observed that inhibition of PKCδ by a pharmacological inhibitor, by gene silencing, or by using K562 CML cells expressing dominant-negative (DN) or constitutively active (CA) PKCδ isoforms clearly points to PKCδ as a regulator of the expression of the stemness regulator BMI1. As a consequence, inhibition of PKCδ impaired clonogenicity and cell proliferation for leukemic cells. PKCδ targeting in K562 and LAMA-84 CML cell lines clearly enhanced the apoptotic response triggered by any TKI. A strong synergism was observed for apoptosis induction through an increase in caspase-9 and caspase-3 activation and significantly decreased expression of the Bcl-xL Bcl-2 family member. Inhibition of PKCδ did not modify BCR-ABL phosphorylation but acted downstream of the oncogene by downregulating BMI1 expression, decreasing clonogenicity. PKCδ inhibition interfered with the clonogenicity of primary CML CD34+ and BCR-ABL-transduced healthy CD34+ cells as efficiently as any TKI while it did not affect differentiation of healthy CD34+ cells. LTC-IC experiments pinpointed that PKCδ inhibition strongly decreased the progenitors/LSCs frequency. All together, these results demonstrate that targeting of PKCδ in combination with a conventional TKI could be a new therapeutic opportunity to affect for CML cells." @default.
- W3139794340 created "2021-04-13" @default.
- W3139794340 creator A5002265683 @default.
- W3139794340 creator A5009789806 @default.
- W3139794340 creator A5011140741 @default.
- W3139794340 creator A5016588330 @default.
- W3139794340 creator A5031309127 @default.
- W3139794340 creator A5042037833 @default.
- W3139794340 creator A5050877697 @default.
- W3139794340 creator A5051395577 @default.
- W3139794340 creator A5051984074 @default.
- W3139794340 creator A5068342352 @default.
- W3139794340 creator A5069793348 @default.
- W3139794340 creator A5083735394 @default.
- W3139794340 creator A5087043304 @default.
- W3139794340 date "2021-04-02" @default.
- W3139794340 modified "2023-10-03" @default.
- W3139794340 title "Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models" @default.
- W3139794340 cites W1513007231 @default.
- W3139794340 cites W1969429198 @default.
- W3139794340 cites W1975386329 @default.
- W3139794340 cites W1985917094 @default.
- W3139794340 cites W1994740077 @default.
- W3139794340 cites W1999882715 @default.
- W3139794340 cites W2009886857 @default.
- W3139794340 cites W2017333581 @default.
- W3139794340 cites W2021033166 @default.
- W3139794340 cites W2026817391 @default.
- W3139794340 cites W2027395744 @default.
- W3139794340 cites W2028319373 @default.
- W3139794340 cites W2028974992 @default.
- W3139794340 cites W2038434637 @default.
- W3139794340 cites W2047122678 @default.
- W3139794340 cites W2050365970 @default.
- W3139794340 cites W2054103222 @default.
- W3139794340 cites W2057466518 @default.
- W3139794340 cites W2058983867 @default.
- W3139794340 cites W2062008885 @default.
- W3139794340 cites W2071317527 @default.
- W3139794340 cites W2071438181 @default.
- W3139794340 cites W2075951376 @default.
- W3139794340 cites W2090982381 @default.
- W3139794340 cites W2100973298 @default.
- W3139794340 cites W2112817157 @default.
- W3139794340 cites W2117356576 @default.
- W3139794340 cites W2120997349 @default.
- W3139794340 cites W2122113546 @default.
- W3139794340 cites W2122224021 @default.
- W3139794340 cites W2130626519 @default.
- W3139794340 cites W2145736651 @default.
- W3139794340 cites W2166666333 @default.
- W3139794340 cites W2167690894 @default.
- W3139794340 cites W2321645860 @default.
- W3139794340 cites W2581785783 @default.
- W3139794340 cites W2766859120 @default.
- W3139794340 cites W2792441886 @default.
- W3139794340 cites W2806530998 @default.
- W3139794340 cites W2905010694 @default.
- W3139794340 cites W2908990432 @default.
- W3139794340 cites W2983410423 @default.
- W3139794340 cites W3009636168 @default.
- W3139794340 cites W3044687690 @default.
- W3139794340 cites W3094086985 @default.
- W3139794340 cites W3100551133 @default.
- W3139794340 doi "https://doi.org/10.3390/cancers13071693" @default.
- W3139794340 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8038300" @default.
- W3139794340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33918475" @default.
- W3139794340 hasPublicationYear "2021" @default.
- W3139794340 type Work @default.
- W3139794340 sameAs 3139794340 @default.
- W3139794340 citedByCount "3" @default.
- W3139794340 countsByYear W31397943402021 @default.
- W3139794340 countsByYear W31397943402022 @default.
- W3139794340 countsByYear W31397943402023 @default.
- W3139794340 crossrefType "journal-article" @default.
- W3139794340 hasAuthorship W3139794340A5002265683 @default.
- W3139794340 hasAuthorship W3139794340A5009789806 @default.
- W3139794340 hasAuthorship W3139794340A5011140741 @default.
- W3139794340 hasAuthorship W3139794340A5016588330 @default.
- W3139794340 hasAuthorship W3139794340A5031309127 @default.
- W3139794340 hasAuthorship W3139794340A5042037833 @default.
- W3139794340 hasAuthorship W3139794340A5050877697 @default.
- W3139794340 hasAuthorship W3139794340A5051395577 @default.
- W3139794340 hasAuthorship W3139794340A5051984074 @default.
- W3139794340 hasAuthorship W3139794340A5068342352 @default.
- W3139794340 hasAuthorship W3139794340A5069793348 @default.
- W3139794340 hasAuthorship W3139794340A5083735394 @default.
- W3139794340 hasAuthorship W3139794340A5087043304 @default.
- W3139794340 hasBestOaLocation W31397943401 @default.
- W3139794340 hasConcept C104317684 @default.
- W3139794340 hasConcept C119056186 @default.
- W3139794340 hasConcept C171122931 @default.
- W3139794340 hasConcept C184235292 @default.
- W3139794340 hasConcept C190283241 @default.
- W3139794340 hasConcept C195794163 @default.
- W3139794340 hasConcept C201750760 @default.
- W3139794340 hasConcept C203014093 @default.
- W3139794340 hasConcept C2776960273 @default.